Merck Sharp & Dohme B.V v. Lupin Limited
Merck Sharp & Dohme B.V v. Lupin Limited is a federal patent - anda lawsuit filed on 03/13/2020 in the District Court, D. New Jersey. The case was terminated on 08/24/2020.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Claire C. Cecchi · 12,702 cases in index
- Docket number
- 2:20-cv-02786
- Nature of suit
- 835
Hatch-Waxman patent disputes over a generic-drug (ANDA) application. - Jurisdiction
- Federal question
- Date filed
- 03/13/2020
- Date terminated
- 08/24/2020
623 Patent - ANDA cases in this court are indexed here.
Parties
- plaintiff · Merck Sharp & Dohme B.V · 21 cases
- defendant · Lupin Limited · 108 cases
About Patent - ANDA Lawsuits
ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
Frequently Asked Questions
What is Merck Sharp & Dohme B.V v. Lupin Limited?
Merck Sharp & Dohme B.V v. Lupin Limited is a federal patent - anda lawsuit filed on 03/13/2020 in the District Court, D. New Jersey. The case was terminated on 08/24/2020. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What type of case is this?
It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 2:20-cv-02786.
When was the case filed?
Merck Sharp & Dohme B.V v. Lupin Limited was filed on 03/13/2020. It was terminated on 08/24/2020.
Other Cases Involving These Parties
Related Patent - ANDA Cases
Source: public U.S. federal court record (docket 16978662).